High Neutrophil-to-Lymphocyte Ratio Is an Early Predictor of Bronchopulmonary Dysplasia
Yuanyuan Sun1† 
Cuie Chen2† 
Xixi Zhang3 
Xiaocai Weng4 
Anqun Sheng1 
Yanke Zhu1 
Shujun Chen2 Xiexia Zheng2 
Chaosheng Lu1*- 1The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
- 2Yiwu Maternity and Children Health Care Hospital, Jinhua, China
- 3Yuhuan People's Hospital, Taizhou, China
- 4Cangnan People's Hospital, Wenzhou, China
Background and Objective: Bronchopulmonary dysplasia (BPD) is a common complication in preterm infants; predicting the degree of BPD at an early life stage is difficult. Inflammation is a crucial risk factor for BPD pathogenesis, and the neutrophil-to-lymphocyte ratio (NLR) is a potential systemic inflammatory biomarker. We aimed to assess the predictive value of the NLR for BPD.
Methods: We carried out a retrospective, single-center, observational study of neonates with gestational ages (GAs) <32 weeks and assessed the association between the NLR and BPD.
Results: The study population included 296 preterm infants with BPD (n = 144) or without BPD (n = 152). Among the infants, 75 (25.3%) had mild BPD, 37 (12.5%) had moderate BPD, and 32 (10.8%) had severe BPD. The BPD group had a higher NLR at birth and at 72 h than the non-BPD group. The NLR cutoff value at 72 h for the prediction of BPD was 3.035 (sensitivity = 0.519, specificity = 0.964), and the area under the curve (AUC) was 0.714. The NLR cutoff value at 72 h for predicting severe BPD was 3.105 (sensitivity = 0.607, specificity = 0.819), with an AUC of 0.756. At the NLR cutoff value at 72 for the prediction of BPD, the AUCs were 0.640 and 0.970 in the preterm infants with EOS and congenital pneumonia, respectively.
Conclusions: The NLR is an inexpensive, accessible and convenient tool; an increase in the NLR at 72 h could be an early predictor of BPD, especially severe BPD. Additionally, the NLR at 72 h could be a predictor of BPD in preterm infants with intrauterine infections.
Introduction
Due to improved neonatal care, the increased use of antenatal steroids, early surfactant and gentle ventilatory support, large numbers of preterm infants survive (1). However, immature lungs, inflammation, infection, hyperoxia, and invasive mechanical ventilation may result in bronchopulmonary dysplasia (BPD), which has become the most frequent respiratory complication among preterm infants (2). BPD is defined as the need for extra oxygen at 4 weeks of age and can be classified as mild, moderate or severe based on the oxygen and ventilatory support at 36 weeks of correct gestational age (3). Recently, BPD has been characterized by immature lung tissue with dysplasia of alveolarization and vascular development (4). Infants with BPD experience prolonged and recurrent hospitalizations, increased rates of other serious prematurity-related complications, possible lifelong cardiopulmonary function alterations, and possible nervous system development disruptions (5, 6). These critical complications are often associated with severe BPD. Despite numerous pharmacologic treatment measures, respiratory care practices, and nutritional therapies, few have demonstrated efficacy in resolving BPD. The clinical prediction of BPD at an early stage in life is difficult but necessary.
Proinflammation is an important pathogenic factor of BPD (7). The levels of several proinflammatory cytokines, such as TNF-α, IL-1β, and IL-6, are increased in BPD patients (7–9), suggesting that an excessive inflammatory response is associated with the onset of BPD. The neutrophil-to-lymphocyte ratio (NLR), could be considered a new potential marker to assess systemic inflammation. A high NLR has been considered to be an independent prognostic indicator for a variety of cancers and cardiovascular diseases, sepsis, infectious conditions and chronic obstructive pulmonary disease (COPD) (10–13). However, the relationship between the NLR and BPD remains unknown.
As inflammation plays a crucial part in the genesis and development of BPD, in this study, we aimed to evaluate the predictive value of the NLR for BPD.
Methods
Patients
All infants born at GA <32 weeks who were hospitalized in the neonatal intensive care unit (NICU) within 6 h after birth between January 2015 and January 2018 were included in the study. BPD was defined and categorized according to the criteria of the National Institute of Child Health and Human Development/National Heart, Lung, and Blood Institute/Office of Rare Diseases (NICHD/NHLBI/ORD) Workshop (3). The study process is presented in Figure 1. Patients with severe congenital dysplasia, including complex congenital heart disease (CHD), congenital gastrointestinal malformations, chromosomal abnormalities, and congenital metabolic diseases, and those with incomplete information or who died were excluded from the study. One with incomplete information because the lack of his mother's medical history. Two dead infants happened on 2 and 3 days after birth, separately. Of the 306 preterm infants initially included in the research, 10 were excluded. Of the remaining 296 infants, 144 infants developed BPD, and 152 infants did not develop BPD. The procedures of this study were conducted in accordance with the World Medical Association Declaration of Helsinki and received ethical approval from the ethical institutional review board of our hospital (the First Affiliated Hospital of Wenzhou Medical University, No. 2018-137). Written informed consent was obtained from the parents of each patient.
Figure 1. Flowchart of the study process.
Data Collection
Information on the following was compiled: sex, gestational age, birth weight, small for gestational age (SGA) status, delivery pattern, Apgar score, premature rupture of membranes (PROM), newborn respiratory distress syndrome (NRDS), early-onset sepsis (EOS), congenital pneumonia, antenatal steroid administration, exogenous surfactant administration, oxygen therapy, BPD classification, mechanical ventilation administration, duration of NICU stay, comorbidities, maternal age, and maternal health status. The definitions of SGA, PROM, NRDS, EOS, and congenital pneumonia were according to the literature (14–18). In our study, the following definitions about EOS were used: (1) EOS was defined as sepsis occurring within 72 h of life. (2) Proven EOS was defined as clinical sepsis presentation with a positive blood culture collected. (3) Neonates with two or more clinical signs and two or more laboratory signs and with a negative blood culture were diagnosed as clinical EOS. Clinical signs were: (1) respiratory symptoms: apnea, tachypnea (respiratory rate > 60/min), sternal and intercostals retractions, cyanosis, respiratory distress; (2) cardiac symptoms: heart rate <100/min or >180/min, hypotension); (3) unstable temperature (rectal, <36.0°C or >38.0°C); (4) digestion symptoms (abdominal distension, bloody stool); (5) poor peripheral circulation or prolonged capillary refilling time (>3 s); (6) irritability, lethargy, or hypotonia. Laboratory signs: (1) White blood cell count < 4,000 × 109/L or >20,000 × 109/L; (2) Platelet count < 100 × 109 /L; (3) CRP > 15 mg/L or PCT ≥ 2 ng/mL. The NLR was calculated as the absolute neutrophil (N) count divided by the absolute lymphocyte (L) count in peripheral blood samples. The NLRs at birth, 72 h, 1 week and 2 weeks after birth were collected.
Statistical Analysis
Continuous variables were expressed as the mean ± standard when normally distributed or the median (interquartile range) when non-normally distributed. The Pearson χ2 test or Fisher's exact test was applied to analyze categorical variables. Comparisons of continuous variables between two groups were performed with t-tests or Wilcoxon tests. The Kruskal–Wallis test was used to analyze differences in continuous variables among three or more groups. Correlation coefficients of continuous variables were calculated and their significance evaluated using the Pearson correlation test. Receiver operating characteristic (ROC) curves were constructed, and the area under the curve (AUC) was obtained to determine the optimal cutoff value. Statistical significance was evaluated at P < 0.05. SPSS version 25.0 (SPSS Inc., Chicago, IL, USA) was used for all data analyses.
Results
Infant Characteristics
Among the 306 preterm infants initially included in the study, 10 were excluded: 2 presented complex congenital heart disease, 1 presented congenital gastrointestinal malformation, 2 presented chromosomal abnormalities, 2 presented congenital metabolic diseases, and 3 had incomplete information or died in 72 h after birth. Of the remaining 296 infants, 144 developed BPD and 152 did not. Information on the infant characteristics is presented in Table 1. The number of cases of mild, moderate and severe BPD were 75 (25.3%), 37 (12.5%), and 32 (10.8%), respectively. The average gestational age was 29.85 ± 1.57 weeks, the average birth weight was 1397.08 ± 324.13 g, and 56.3% of the patients were males. Infants who developed BPD had a significantly lower gestational age and birth weight than those who did not develop BPD. Patients with Apgar scores <7, NRDS, EOS, or congenital pneumonia and patients born to a mother with a multiple pregnancy, cesarean delivery, or gestational diabetes mellitus or had received antenatal steroid therapy had increased rates of BPD. In the BPD group, the duration of mechanical ventilation, including continuous positive airway pressure (CPAP) therapy and synchronized intermittent mandatory ventilation (SIMV) therapy, was significantly longer than that in the non-BPD group. Relative to infants who did not develop BPD, infants who developed BPD had increased rates of intravenous nutrition therapy, increased lengths of NICU stay, and substantially increased hospital costs. Among the 122 patients with EOS, 17 patients had positive blood cultures for one of the following Escherichia coli (4 patients), Klebsiella pneumoniae (4 patients), Enterobacter cloacae (2 patients), Monilia albicans (2 patients), Staphylococcus epidermidis (4 patients), and Staphylococcus warneri (1 patient).
Table 1. Baseline characteristics of patients between BPD group and without BPD group.
Comparison of the NLR Between the BPD Group and the Non-BPD Group
The NLR was compared between the BPD group and the non-BDP group for the entire period under study. The results are shown in Table 2. Relative to the N count in the non-BDP group, the N count in the BPD group was significantly increased at birth (7.64 ± 7.37 vs. 5.35 ± 3.72, P = 0.001) and at 72 h (7.95 ± 7.32 vs. 4.26 ± 2.80, P = 0.000), 1 week (7.24 ± 6.76 vs. 4.35 ± 5.12, P = 0.028) and 2 weeks (4.11 ± 2.82 vs. 3.53 ± 1.61, P = 0.036) of age. Relative to the NLR in the non-BDP group, the NLR in the BPD group was significantly increased at birth (3.04 ± 4.68 vs. 2.12 ± 2.99, P = 0.043) and at 72 h of age (2.77 ± 1.65 vs. 1.44 ± 1.09, P = 0.001).
Table 2. The NLR of patients between BPD group and without BPD group.
Comparison of the NLR Among Groups With Different Severities of BPD
All of the BPD subjects were stratified into mild, moderate and severe BPD groups (Table 3). The N count in the severe BPD group was higher than that in the mild BPD group at birth (10.19 ± 10.21 vs. 6.72 ± 5.49, P = 0.004), 72 h (9.84 ± 8.07 vs. 6.32 ± 5.05, P = 0.016), 1 week (9.92 ± 10.51 vs. 6.12 ± 4.73, P = 0.031) and 2 weeks (5.10 ± 4.16 vs. 3.61 ± 1.87, P = 0.003) and was higher than that of the moderate BPD group at birth (10.19 ± 10.21 vs. 7.29 ± 7.47, P = 0.037). The NLR of the severe BPD group was higher than that of the mild BPD group at 72 h (3.411 ± 2.19 vs. 2.08 ± 1.23, P = 0.013), 1 week (2.23 ± 2.07 vs. 1.42 ± 0.98, P = 0.038), and 2 weeks (1.23 ± 1.01 vs. 0.83 ± 0.69, P = 0.044). There was no significant difference in L count between the severe BPD group and either of the other two groups.
Table 3. The NLR of patients among varying degrees BPD groups.
Parameters Predictive of BPD
After analyzing the correlations of the N and L counts and the NLR between the BPD and non-BPD patients, we constructed ROC curves to obtain the sensitivity, specificity and cutoff point of each of the significant parameters for the prediction of BPD. The ROC curves of N count and the NLR for the prediction of BPD are displayed in Figures 2A–E. The AUCs for the NLR at 72 h, N count at 72 h, and N count at 1 week were 0.714, 0.661, and 0.671, respectively. The most accurate discriminatory NLR for BPD at the 72 h threshold was 3.035 (sensitivity = 0.519, specificity = 0.964).
Figure 2. The ROC curves of the NLR and N count for the prediction of BPD (A–E) and severe BPD (F–J).
Parameters Predictive of Severe BPD
After analyzing the correlations of the N and L counts and the NLR among the groups of patients with differing severity of BPD, we constructed ROC curves to obtain the sensitivity, specificity and cutoff point of each of the significant parameters for the prediction of severe BPD in Figures 2F–J. The AUCs for the N at 72 h and 1 week were 0.632 and 0.642, respectively. The AUCs for the NLR at 72 h and 2 weeks were 0.756 and 0.66, respectively. The most accurate discriminatory NLR at the 72 h threshold was 3.105 (sensitivity = 0.607, specificity = 0.819) for severe BPD.
Comparison of the NLR Between the BPD Group and Non-BDP Group Among Preterm Infants With or Without EOS
As BPD is associated with intrauterine infection, we divided the preterm infants into an EOS group and a non-EOS group. Comparison of the NLR between the BPD group and non-BDP group of EOS and non-EOS patients were then performed. The results are shown in Table 4. In the EOS group, compared to the patients without BPD, the BPD patients had a higher N count at birth (8.10 ± 7.99 vs. 4.18 ± 2.96, P = 0.000), 72 h (8.91 ± 7.96 vs. 3.91 ± 3.35, P = 0.000), 1 week (7.53 ± 6.53 vs. 4.09 ± 3.28, P = 0.039) and 2 weeks (4.07 ± 3.31 vs. 2.72 ± 1.62, P = 0.003). Similarly, in the non-EOS group, compared to the patients without BPD, those with BPD had a higher N count at birth (7.64 ± 7.05 vs. 5.42 ± 3.08, P = 0.015). Among the patients with BPD, N count was higher in the EOS group than the non-EOS group at 72 h (8.91 ± 7.96 vs. 5.95 ± 4.07, P = 0.014). These results indicated that the N count at birth was a significant indicator of BPD regardless of EOS status, whereas the N count at 72 h, 1 and 2 weeks was a significant predictor of BPD only in EOS patients. Additionally, in the EOS group, compared to the patients without BPD, the BPD patients had a higher NLR at birth (3.59 ± 2.96 vs. 1.66 ± 1.22, P = 0.011), 72 h (2.32 ± 1.87 vs. 1.64 ± 1.55, P = 0.031) and 2 weeks (1.05 ± 1.12 vs. 0.55 ± 0.30, P = 0.007). There was no difference in the NLR between the BPD and non-BPD patients in the non-EOS group. Among the patients with BPD, the NLR was higher in those patients with EOS than in those without at 72 h (2.32 ± 1.87 vs. 1.76 ± 0.73, P = 0.040). These results indicated that NLR was a significant indicator of BPD in EOS patients.
Table 4. The NLR between BPD group and without BPD group in the preterm infants with EOS or not.
Comparison of the NLR Between the BPD Group and Non-BDP Group Among Patients With or Without Congenital Pneumonia
The NLR was compared between the BPD group and non-BDP group among patients with congenital pneumonia and those without. The results are shown in Table 5. Among the patients with congenital pneumonia, compared to the non-BPD patients, the BPD patients had a higher N count (10.49 ± 9.84 vs. 2.23 ± 1.40, P = 0.014) and higher NLR (2.80 ± 1.83 vs. 0.49 ± 0.29, P = 0.002) at 72 h. Among the patients without congenital pneumonia, compared to the non-BPD patients, the BPD patients had a higher N count at birth (7.06 ± 6.68 vs. 5.11 ± 3.13, P = 0.007), 72 h (6.94 ± 6.67 vs. 4.33 ± 2.82, P = 0.004) and 2 weeks (4.15 ± 2.70 vs. 3.54 ± 1.62, P = 0.046) and had a higher L count (3.51 ± 1.42 vs. 3.07 ± 1.01, P = 0.023) and NLR (1.90 ± 1.55 vs. 1.48 ± 1.09, P = 0.038) at 72 h. Additionally, among the patients with BPD, N count was higher in the patients with congenital pneumonia than in those without at birth (10.24 ± 0.36 vs. 7.06 ± 6.68, P = 0.003), 72 h (10.49 ± 9.84 vs. 6.94 ± 6.67, P = 0.010) and 1 week (9.99 ± 6.62 vs. 6.26 ± 5.59), and the NLR was higher in those patients with congenital pneumonia than in those without at 72 h (2.80 ± 1.83 vs. 1.90 ± 1.55, P = 0.003) and 1 week (2.29 ± 1.36 vs. 1.52 ± 1.39, P = 0.033).
Table 5. The NLR between BPD group and without BPD group in the preterm infants with congenital pneumonia or not.
Parameters Correlated With BPD in Preterm Infants With and Without Intrauterine Infections
After analyzing the correlations of the N and L counts and the NLR between BPD patients and non-BPD patients in preterm infants with intrauterine infections and those without, we constructed ROC curves to obtain the sensitivity, specificity, and cutoff point of each the significant parameters for the prediction of BPD. The ROC curves of the NLR and N count for the prediction of BPD in preterm infants with EOS are displayed in Figures 3A–D. The AUCs for the N count at birth, 72 h and 1 week were 0.629, 0.683, and 0.711, respectively. The most accurate discriminatory N count for BPD at the 1 week threshold was 3.60 (sensitivity = 0.620, specificity = 0.857). The NLR cutoff value at birth was 1.95 (sensitivity = 0.568, specificity = 0.725), with an AUC of 0.642, and the NLR cutoff value at 72 h was 0.99 (sensitivity = 0.775, specificity = 0.464), with an AUC of 0.640. The ROC curves of N count and the NLR for the prediction of BPD in preterm infants with congenital pneumonia are displayed in Figures 3E,F. The N cutoff value at 72 h was 2.10 (sensitivity = 0.963, specificity = 0.750), with an AUC of 0.907. The NLR cutoff value at 72 h was 0.97 (sensitivity = 0.889, specificity = 1), with an AUC of 0.972.
Figure 3. The ROC curves of the NLR and N count for the prediction of BPD in preterm infants with intrauterine infection. (A–D) Preterm infants with EOS. (E,F) Preterm infants with congenital pneumonia.
Discussion
In the present study, we found that an increase in the NLR (at birth and at 72 h) was associated with BPD. Moreover, the NLR at 72 h was found to be the most promising marker for predicting BPD, especially severe BPD, at an early stage of life. Additionally, the NLR at 72 h was identified as a predictor of BPD in preterm infants with congenital infections.
BPD is a severe chronic pulmonary disease of preterm infants that involves the disruption of alveolar and pulmonary vascular development. Inflammation is a well-known critical risk factor in the pathogenesis of BPD. Many studies have suggested an association between elevated levels of proinflammatory cytokines and BPD in patients (19–21). In the course of BPD, Ns and macrophages play crucial roles in lung and systemic inflammation in extrapulmonary tissue. In a previous study, preterm infants with NRDS who subsequently developed BPD had much higher and persistent numbers of Ns and macrophages in their bronchoalveolar lavage fluid than did those who recovered (22). Most likely, Ns are activated during inflammation and adhere to endothelial cells in the pulmonary vascular system, which triggers a series of injurious events. Ns are the first cellular defense of the natural immune system, with a short half-life, whereas Ls are the main cells of the adaptive immune system. N count has been demonstrated as early biomarker of BPD in preterm infants at birth (20, 23). In our study, we found that increases in N count at birth, 72 h, 1 week and 2 weeks were associated with BPD; this association may be due to inflammation in the pulmonary and peripheral blood, especially the assembly of Ns. Our ROC analysis also indicated that N counts at 72 h and 1 week predicted BPD.
In recent years, the NLR has become a widely available marker of inflammation. Elevated NLR can be used as a marker similar to C-reactive protein (CRP) in the determination of increased inflammation in acutely exacerbated COPD (24). The NLR has been found to be more accurate than CRP in the prediction of bacteremia or the severity of community-acquired pneumonia (25). In a previous study, patients with septic shock at risk of early death had lower NLR at admission, and late death was associated with higher NLR at the first 5 days (10). We found that the NLR in the BPD group was higher than that in the BPD group at birth and 72 h, whereas the highest NLR was found in severe BPD patients. We confirmed that the NLR at 72 h had the capacity to predict BPD and severe BPD. A high NLR reflects systemic inflammation, which is strongly associated with BPD. We also confirmed that N count is significantly correlated with severe BPD; however, N count is not as relevant as the NLR. It is therefore reasonable to postulate that the NLR reflects the severity of BPD better than N or L count alone.
Intrauterine infections, such as EOS and congenital pneumonia, can lead to pulmonary inflammation, which increases the risk of BPD. We investigated the correlation between the NLR and BPD in preterm infants with and without intrauterine infections. Among the 122 patients with EOS, only 17 patients were positive for blood culture, so it was not possible to clarify the correlation between the NLR and BPD for different pathogens. However, we found that infants with EOS or congenital pneumonia had significantly higher rates of BPD and a higher NLR value at 72 h than did infants without these infections. Furthermore, infants with EOS had significantly higher values of NLR at birth and at 2 weeks, which indicated that the NLR is increased at an early stage in the presence of systemic inflammation, and the NLR was associated with an increased risk of BPD. We also confirmed that the NLR at 72 h was predictive of BPD with EOS or congenital pneumonia; however, this finding should be interpreted with caution as the sample size was low.
This study found that the NLR was a stronger predictor of BPD than was N count, which may provide a new basis for the future prevention and treatment of BPD. An increased NLR was associated with an elevated N count, suggesting that an increased neutrophil count in the early blood circulation is associated with the occurrence of BPD. Interestingly, neutrophil extracellular traps (NETs) formed by neutrophil elastase (NE), DNA, histones, and myeloperoxidase (MPO) (26) have been shown to mediate proinflammatory effects in vivo and in vitro and have served as useful biomarkers for a variety of diseases, including sepsis, acute lung injury, cystic fibrosis and COPD (27–29). Additionally, previous studies found that the activated neutrophilic polymorphonuclear leukocyte (PMN)-derived exosome was related to the pathogenesis of BPD in extracellular matrix (ECM) homeostasis disorders (30). We speculate that a high NLR leads to NET overexpression and activates PMN to release exosomes, thereby playing significant roles in the progression of BPD. This speculation will be investigated in a future study.
The present study has some limitations. First, the study was a single-center, retrospective, observational study; thus, the potential for residual confounding could not be eliminated. The results must be confirmed by studies at other centers. Second, we did not measure conventional proinflammatory markers such as CRP, IL-6, or prostate calcitonin (PCT) and analyze the correlations of these parameters with N count and the NLR.
In summary, we found that the NLR at 72 h might be considered an early significant indicator of both BPD and severe BPD in preterm infants, including those with intrauterine infections. The individualization of therapeutic interventions should be considered based on this marker.
What is Known
Bronchopulmonary dysplasia is a common complication in preterm infants; predicting the degree of BPD at an early life stage is difficult. Inflammation is a crucial risk factor for BPD pathogenesis, and the NLR is a potential systemic inflammatory biomarker.
What is New
In the present study, we found that the NLR at 72 h might be considered an early significant indicator of both BPD and severe BPD in preterm infants, including those with intrauterine infections.
Data Availability Statement
All datasets generated for this study are included in the article/Supplementary Material.
Ethics Statement
The study was conducted ethically in accordance with the World Medical Association Declaration of Helsinki and received ethical approval from the ethical institutional review board of our hospital (the First Affiliated Hospital of Wenzhou Medical University, No. 2018–137). We obtained written informed consent from all patient guardians in this study.
Author Contributions
YS provided the idea of this experiments and managed it, and provided fund. CC managed the experiments, analyzed the results, and was involved in manuscript preparation. XZha and AS were involved in data collection and analysis. XW analyzed the results and was involved in manuscript preparation. YZ was involved in manuscript preparation. SC analyzed the results. XZhe data collection. CL provided the idea of this experiments and managed it.
Funding
This study was supported by Wenzhou Municipal Science and Technology Bureau, China (Y20140497), Yiwu Municipal Science and Technology Bureau, China (19-3-41 and 17-1-17), and Zhejiang Province Medical Science and Technology Project (2020366886).
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Supplementary Material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fped.2019.00464/full#supplementary-material
Supplementary Table 1. The original data of the research.
Abbreviations
BPD, bronchopulmonary dysplasia; SGA, small for gestational age; NRDS, newborn respiratory distress syndrome; CHD, congenital heart disease; EOS, early-onset sepsis; PROM, premature rupture of membranes; CPAP, continuous positive airway pressure; SIMV, synchronized intermittent mandatory ventilation; WBC, white blood cell; N, neutrophil; L, lymphocyte; P, platelet; NLR, neutrophil-to-lymphocyte ratio; RBT, routine blood test; GA, gestational age; AUC, area under the curve; COPD, chronic obstructive pulmonary disease; ROC, receiver operating characteristic; GBS, Streptococcus agalactiae; NETs, neutrophil extracellular traps; MPO, myeloperoxidase; NE, neutrophil elastase; CRP, C reaction protein; PCT, prostate calcitonin.
References
1. Field DJ, Dorling JS, Manktelow BN, Draper ES. Survival of extremely premature babies in a geographically defined population: prospective cohort study of 1994–9 compared with 2000–5. BMJ. (2008) 336:1221–3. doi: 10.1136/bmj.39555.670718.BE
2. McEvoy CT, Jain L, Schmidt B, Abman S, Bancalari E, Aschner JL. Bronchopulmonary dysplasia: NHLBI workshop on the primary prevention of chronic lung diseases. Ann Am Thorac Soc. (2014) 11 (Suppl. 3):S146–53. doi: 10.1513/AnnalsATS.201312–424LD
3. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. (2001) 163:1723–9. doi: 10.1164/ajrccm.163.7.2011060
4. Baker CD, Alvira CM. Disrupted lung development and bronchopulmonary dysplasia: opportunities for lung repair and regeneration. Curr Opin Pediatr. (2014) 26:306–14. doi: 10.1097/MOP.0000000000000095
5. Gibson AM, Reddington C, McBride L, Callanan C, Robertson C, Doyle LW. Lung function in adult survivors of very low birth weight, with and without bronchopulmonary dysplasia. Pediatr Pulmonol. (2015) 50:987–94. doi: 10.1002/ppul.23093
6. Lin F, Dong H, Song Y, Zhang T, Qi J, Xiao X, et al. Effect of bronchopulmonary dysplasia on early intellectual development in preterm infants. Pediatr Int. (2017) 59:691–7. doi: 10.1111/ped.13257
7. Speer CP. Inflammation and bronchopulmonary dysplasia: a continuing story. Semin Fetal Neonatal Med. (2006) 11:354–62. doi: 10.1016/j.siny.2006.03.004
8. Köksal N, Kayik B, Çetinkaya M, Özkan H, Budak F, Kiliç S, et al. Value of serum and bronchoalveolar fluid lavage pro- and anti-inflammatory cytokine levels for predicting bronchopulmonary dysplasia in premature infants. Eur Cytokine Netw. (2012) 23:29–35. doi: 10.1684/ecn.2012.0304
9. Rocha G, Proenca E, Guedes A, Carvalho C, Areias A, Ramos JP, et al. Cord blood levels of IL-6, IL-8 and IL-10 may be early predictors of bronchopulmonary dysplasia in preterm newborns small for gestational age. Dis Markers. (2012) 33:51–60. doi: 10.1155/2012/925632
10. Riche F, Gayat E, Barthelemy R, Le Dorze M, Mateo J, Payen D. Reversal of neutrophil-to-lymphocyte count ratio in early versus late death from septic shock. Crit Care. (2015) 19:439. doi: 10.1186/s13054–015-1144-x
11. Afari ME, Bhat T. Neutrophil to lymphocyte ratio (NLR) and cardiovascular diseases: an update. Exp Rev Cardiovasc Therap. (2016) 14:573–7. doi: 10.1586/14779072.2016.1154788
12. Faria SS, Fernandes PC Jr, Silva MJ, Lima VC, Fontes W, Freitas-Junior R, et al. The neutrophil-to-lymphocyte ratio: a narrative review. Ecancermedicalscience. (2016) 10:702. doi: 10.3332/ecancer.2016.702
13. Inoue D, Sekiguchi S, Yamagata W, Maeda G, Yamada D, Fujiwara S, et al. Elevation of neutrophil-to-lymphocyte ratio before first-line chemotherapy predicts a poor prognosis for second-line chemotherapy in gastric cancer. Oncology. (2019) 96:140–6. doi: 10.1159/000493427
14. Zhang J, Han L, Li W, Chen Q, Lei J, Long M, et al. Early prediction of preeclampsia and small-for-gestational-age via multi-marker model in Chinese pregnancies: a prospective screening study. BMC Pregnancy Childbirth. (2019) 19:304. doi: 10.1186/s12884–019-2455–8
15. Berger R, Abele H, Bahlmann F, Bedei I, Doubek K, Felderhoff-Müser U, et al. Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) - Part 2 with recommendations on the tertiary prevention of preterm birth and the management of preterm premature rupture of membranes. Geburtshilfe Frauenheilkd. (2019) 79:813–33. doi: 10.1055/a-0903–2735
17. Simonsen KA1, Anderson-Berry AL, Delair SF, Davies HD. Early-onset neonatal sepsis. Clin Microbiol Rev. (2014) 27:21–47. doi: 10.1128/CMR.00031–13
18. Nissen MD. Congenital and neonatal pneumonia. Paediatr Respir Rev. (2007) 8:195–203. doi: 10.1016/j.prrv.2007.07.001
19. Bhandari V. Postnatal inflammation in the pathogenesis of bronchopulmonary dysplasia. Birth defects research Part A. Clin Mol Teratol. (2014) 100:189–201. doi: 10.1002/bdra.23220
20. Zhang ZQ, Huang XM, Lu H. Early biomarkers as predictors for bronchopulmonary dysplasia in preterm infants: a systematic review. Eur J Pediatr. (2014) 173:15–23. doi: 10.1007/s00431–013-2148–7
21. Shahzad T, Radajewski S, Chao CM, Bellusci S, Ehrhardt H. Pathogenesis of bronchopulmonary dysplasia: when inflammation meets organ development. Mol Cell Pediatr. (2016) 3:23. doi: 10.1186/s40348–016-0051–9
22. Ogden BE, Murphy SA, Saunders GC, Pathak D, Johnson JD. Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance. Am Rev Respir Dis. (1984) 130:817–21. doi: 10.1164/arrd.1984.130.5.817
23. Inoue H, Ohga S, Kusuda T, Kitajima J, Kinjo T, Ochiai M, et al. Serum neutrophil gelatinase-associated lipocalin as a predictor of the development of bronchopulmonary dysplasia in preterm infants. Early Hum Dev. (2013) 89:425–9. doi: 10.1016/j.earlhumdev.2012.12.011
24. Farah R, Ibrahim R, Nassar M, Najib D, Zivony Y, Eshel E. The neutrophil/lymphocyte ratio is a better addition to C-reactive protein than CD64 index as a marker for infection in COPD. Panminerva Med. (2017) 59:203–209. doi: 10.23736/S0031-0808.17.03296-7
25. Furutate R, Ishii T, Motegi T, Hattori K, Kusunoki Y, Gemma A, et al. The neutrophil to lymphocyte ratio is related to disease severity and exacerbation in patients with chronic obstructive pulmonary disease. Int Med. (2016) 55:223–9. doi: 10.2169/internalmedicine.55.5772
26. Li RHL, Tablin F. A Comparative review of neutrophil extracellular traps in sepsis. Front Vet Sci. (2018) 5:291. doi: 10.3389/fvets.2018.00291
27. Liu S, Su X, Pan P, Zhang L, Hu Y, Tan H, et al. Neutrophil extracellular traps are indirectly triggered by lipopolysaccharide and contribute to acute lung injury. Sci Rep. (2016) 6:37252. doi: 10.1038/srep37252
28. Martinez-Aleman SR, Campos-Garcia L, Palma-Nicolas JP, Hernandez-Bello R, Gonzalez GM, Sanchez-Gonzalez A. Understanding the Entanglement: Neutrophil Extracellular Traps (NETs) in Cystic Fibrosis. Front Cell Infection microbiol. (2017) 7:104. doi: 10.3389/fcimb.2017.00104
29. Uddin M, Watz H, Malmgren A, Pedersen F. NETopathic inflammation in chronic obstructive pulmonary disease and severe asthma. Front Immunol. (2019) 10:47. doi: 10.3389/fimmu.2019.00047
Keywords: bronchopulmonary dysplasia, neutrophil-to-lymphocyte ratio, predictor, inflammation, intrauterine infections
Citation: Sun Y, Chen C, Zhang X, Weng X, Sheng A, Zhu Y, Chen S, Zheng X and Lu C (2019) High Neutrophil-to-Lymphocyte Ratio Is an Early Predictor of Bronchopulmonary Dysplasia. Front. Pediatr. 7:464. doi: 10.3389/fped.2019.00464
Received: 10 June 2019; Accepted: 24 October 2019;
Published: 12 November 2019.
Edited by:
Karel Allegaert, University Hospitals Leuven, BelgiumReviewed by:
Hercília Guimarães, University of Porto, PortugalMaryAnn Volpe, Tufts University School of Medicine, United States
Copyright © 2019 Sun, Chen, Zhang, Weng, Sheng, Zhu, Chen, Zheng and Lu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Chaosheng Lu, lucs363@163.com
†These authors have contributed equally to this work and share first authorship